A Brian Davis's Net Worth
-$7.66 Thousand
Who is A Brian Davis?
A Brian Davis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verrica Pharmaceuticals Inc., Strongbridge Biopharma plc, TENGION INC, Acasti Pharma Inc., and NEOSE TECHNOLOGIES INC.
SEC CIK
A Brian Davis's CIK is 0001184432
Past Insider Trading and Trends
2004 was A Brian Davis's most active year for acquiring shares with 5 total transactions. A Brian Davis's most active month to acquire stocks was the month of January. 2006 was A Brian Davis's most active year for disposing of shares, totalling 2 transactions. A Brian Davis's most active month to dispose stocks was the month of June. 2005 saw A Brian Davis paying a total of $296,694.42 for 84,672 shares, this is the most they've acquired in one year. In 2018 A Brian Davis cashed out on 8,696 shares for a total of $57,393.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Verrica Pharmaceuticals Inc. (VRCA) Snapshot price: $1.9099
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +63.29% | 5K |
$9.89 | $49,450.00 | 12.9K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 7.9K |
$6.24 | $49,296.00 | 7.9K |
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Strongbridge Biopharma plc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +149.63% | 20K |
—
|
—
| 33.37K |
Feb 20
| |||
Form 4
| -39.42% | -8.70K |
$6.60 | -$57,393.60 | 13.37K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TENGION INC No price found
Chf. Fin. Offr, VP Fin & Treas
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acasti Pharma Inc. (ACST) Snapshot price: $2.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEOSE TECHNOLOGIES INC No price found
Sr. Vice President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +65.50% | 11.46K |
$2.00 | -$9,390.00 | 28.95K |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +162.61% | 10.83K |
$2.78 | -$10,035.80 | 17.5K |
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +3.56% | 229 |
$5.65 | $1,294.42 | 6.66K |
Jan 31 - Feb 24
| |||
Form 4
| +7.58% | 453 |
$5.86 | $2,652.99 | 6.43K |
Jul 30
| |||
Form 4
| +14.10% | 739 |
$6.77 | $5,003.03 | 5.98K |
May 17
| |||
Form 4
| +1.37% | 71 |
$10.20 | $724.20 | 5.24K |
Jan 30 - Feb 3
| |||
Form 4
| +1.55% | 79 |
$8.87 | $701.05 | 5.17K |
Jul 31
| |||
| No matching records found | |||||||||